Skip to content
Get the Balanced News app for a better experience!
The Balanced News Logo
Analytics
The Balanced News Logo

Stay Balanced, Stay Informed

Menu
  • Browse News
  • Underreported Stories
  • Curated Feeds
  • Insights
  • Analytics
  • Our Writers
  • About Us
  • Download App
Learn
  • How It Works
  • Bias Detection
  • Lens Score
  • Source Bias Checker
  • Accountability
  • Custom Feeds
Newsroom
  • Writers & Analysts
  • About TBN
  • Editorial Standards
  • Corrections Policy
  • Our Partners
  • Insights
Socials
  • Youtube
  • Instagram
  • X
  • Facebook
News Categories
  • Trending
  • Politics
  • Sports
  • Business
  • Tech
  • Entertainment
  • Health
  • Science
  • Crime
  • Lifestyle
  • National
  • International
  • Good News
  • Crypto

Get Our App

Available for iOS and Android


LensFeedsInsightsAnalyticsTrendingGood NewsSportsPoliticsBusinessCrimeTechEntertainmentHealthNationalInternational

© 2026 The Balanced News. All rights reserved.

About UsEditorial StandardsCorrectionsHelp & SupportPrivacy PolicyTerms & Conditions
Pharma Company Gufic Buys Luxury Duplex in Mumbai's Juhu for Rs 236 Crore

Categories

Categories

Related Coverage

Select a news story to see related coverage from other media outlets.

Related Coverage

Select a news story to see related coverage from other media outlets.

  1. Home
  2. /
  3. Business

Pharma Company Gufic Buys Luxury Duplex in Mumbai's Juhu for Rs 236 Crore

Analysed 31 Oct 2026·3 sources analysed·Mumbai, India·Business
Pharma Company Gufic Buys Luxury Duplex in Mumbai's Juhu for Rs 236 CrorePreviousNext

Pharmaceutical company Gufic Pvt. Ltd purchased a luxury duplex apartment in Mumbai's Lodha Avalon project on Juhu Tara Road for Rs 236.33 crore. The 14th-floor property spans 19,694 sq ft with 10 parking spaces, valuing it at about Rs 1.2 lakh per sq ft. This transaction, registered in October 2026, reflects a growing trend of pharma promoters investing in high-value luxury residences in Mumbai's upscale neighborhoods. Previous similar purchases by pharma executives have also been noted in the same project.

Sentiment
50%
TBN's observations

First-hand measurement across 3 sources

We measured how 3 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (50/100). Lens Score 38/100.

Outlets measured: mint, economictimes, hindustantimes. See how each one headlined and framed the same story in the source comparison below.

AI analysis of 3 sources · Published under editorial oversight by The Balanced News
Analysed 31 Oct 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Sentiment — Neutral (50/100)

Sentiment was consistent across outlets (50–50/100), indicating broadly factual reporting rather than editorialising.

Coverage timeline

hindustantimes broke this story on 31 Oct, 11:37 am. Other outlets followed.

31 Oct, 11:37 am3 sources · 17 min31 Oct, 11:54 am
AI analysis by the TBN Bias Engine · beat methodology byMrunal Wange· Business & Economy Editor· editorial standards byOjas Kale
← Previous
Diwali 2026: Emerging Trends in Thoughtful and Unique Festive Gifting
Next →
Silver Touch Technologies Reports 21% Income Growth and Doubled Profit in H1 FY27
  1. 1
    hindustantimes31 Oct, 11:37 am
    Pharma company Gufic Private Limited buys luxury duplex apartment in Mumbai for more than 236 crore
  2. 2
    economictimes31 Oct, 11:47 am
    Pharma company Gufic buys luxury duplex in Mumbai's Juhu for over Rs 236 cr
  3. 3
    mint31 Oct, 11:54 am
    Pharma company Gufic buys Lodha Avalon duplex in Juhu for 236 crore

Who's involved

Institutions and figures named across source coverage.

Corporate
Macrotech Developers LimitedV Hotels LimitedGufic Private LimitedEncube EthicalsUSVSahastraa Advisors Private LimitedGufic Pharmaceuticals LimitedSahastraa AdvisorsAatman Innovations Private LimitedLodha Developers
Judiciary
National Company Law Tribunal

Story context

Category
Business
Location
Mumbai, India
Sources analysed
3
Last analysed
31 Oct 2026
Key entities
Pharmaceutical industryCroreIndian rupeeMumbaiJuhuLakhReal estate economicsChief executive officerWorliTara RoadReal estateMarketing